Business Wire

Sight Diagnostics’ OLO Deployed in Israeli Hospital to Help Support Coronavirus Quarantine Measures

Share

Sight and Sheba Tel Hashomer today announced their new collaboration aimed at mitigating the risk of contamination by COVID-19. Sight’s OLO blood analyser will provide rapid FBC (full blood count) results in a dedicated lab within Israel’s flagship government-run hospital, to process samples of infected patients who are being monitored and treated in a separate field hospital.

Prior to deploying OLO for coronavirus patient testing, Sight ran a two-month evaluation at the central lab of Sheba Tel Hashomer, one of the top 10 hospitals in the world, according to Newsweek, and one of the biggest in Israel. The successful results led to implementing OLO for FBC testing.

Currently, OLO is being used for routine testing of Sheba’s positive coronavirus patients. “OLO’s compact design makes it easy to set up quickly in a setting reserved for testing only contagious blood samples. Eliminating the risks of processing these samples alongside regular lab samples is uniquely advantageous in managing outbreaks of highly infectious diseases,” said Dr. Ram Doolman, Director of Sheba’s Laboratories Division and Automated Mega-Laboratory. “By setting up a quarantined lab that requires special protocols in handling samples from infected patients, we are taking the necessary steps to protect our staff who are on the frontlines, fighting the coronavirus epidemic.”

“Typically, monitoring a patient infected with a virus like COVID-19 would involve taking a blood sample from the infected individual with a needle, labeling vials of drawn blood, sending those vials to a lab outside of the quarantine zone, and receiving the results of the test an hour or more later,” said Yossi Pollak, CEO of Sight. “OLO gives health care providers the ability to use a self-contained cartridge to collect two drops of blood, from either a venous or finger prick sample, insert the cartridge into OLO, and receive FBC results in minutes. For health facilities in countries where OLO is available for point-of-care use, that tactical advantage could make a big difference in a field setting.”

OLO’s technology combines computer vision and AI to digitise each blood sample into more than 1,000 high resolution images. ”We are planning to further develop our technology to diagnose serious conditions, including complications that stem from a viral infection, that have a distinct visual signature in the blood sample,” said Yochay Eshel, VP of R&D at Sight. “We believe in the impact our technology could have on the management of infectious disease, and we are keen to do our part to help.”

Sight is committed to providing rapid and accurate blood tests to aid health professionals in diagnosing and treating patients around the world. By applying technological innovation to blood diagnostics, Sight hopes to improve the ways in which healthcare professionals tackle the challenging effects of infectious diseases.

CAUTIONARY STATEMENT: This press release is intended for distribution outside of the United States. OLO has the CE Mark registration from the European directive for performing FBC tests in point of care settings. In the United States, OLO is 510(k) cleared for use in moderate complexity laboratories; it has not yet been cleared for point of care use.

About Sight Diagnostics
Founded in 2011, Sight Diagnostics aims to transform health systems and patient outcomes through accurate and pain-free blood diagnostic testing. Sight’s technology, developed over almost a decade of research, represents breakthrough innovations in diagnostic methodology. Sight’s latest blood analyser, OLO, performs a Full Blood Count, the most commonly ordered blood test, in minutes. It’s compact: designed to be used in a variety of settings. OLO creates a digital version of a blood sample by capturing more than 1,000 highly detailed images from just two drops of blood obtained from a finger prick or venous sample. These images are then interpreted by proprietary and fully automated AI algorithms. Sight’s first product, Parasight, has been used to detect malaria in almost 1 million tests across 24 countries. The company has rapidly growing offices in the UK, the US and Israel. Learn more at sightdx.com.

Contact information

Emma Baron
Senior Account Executive
VSC for Sight Diagnostics
sight@vsc.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Campaign29.3.2020 23:10:00 EESTPress release

Zynga (NASDAQ:ZNGA): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200328005018/en/ Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Campaign WHAT Today, the global and far-reaching games industry agreed to disseminate key messages from the World Health Organization to help slow the spread of COVID-19. To promote these messages, 18 game industry leaders in the interactive entertainment space have launched #PlayApartTogether, an initiative that encourages their vast network of users to follow the WHO’s health guidelines—including physical distancing, hand hygiene, respiratory etiquette and other powerful preventive actions people can take to fight COVID-19. By bringing special events, exclusives, activities, rewards and inspiration to some of the most popular games in the world, #PlayApartTogether encourages users to adopt best practices for the sake of their own

Jack Ma Foundation and Alibaba Foundation Donate to Seven More Countries in Asia to Fight COVID-1929.3.2020 07:58:00 EESTPress release

The Jack Ma Foundation and the Alibaba Foundation today announced donations of essential medical supplies to seven more countries, namely Azerbaijan, Bhutan, India, Kazakhstan, Kyrgyzstan, Uzbekistan and Vietnam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200328005024/en/ An India bound flight loaded with the first batch of medical supplies donated by the Jack Ma Foundation and Alibaba Foundation departed Shanghai, China yesterday. The donations arrived at New Delhi's Indira Gandhi International Airport last night and were received by the Indian Red Cross Society which would help distribute the supplies across the country. The supplies are part of the donation pledged to seven more countries announced today by the two foundations, namely Azerbaijan, Bhutan, India, Kazakhstan, Kyrgyzstan, Uzbekistan and Vietnam. (Photo: Business Wire) Collectively, these seven countries will receive a total of 1.7 million face masks, 165,

P&G Joins Forces with the Red Cross and Red Crescent Network to Provide Emergency Relief and Serve European Communities During COVID-19 Pandemic27.3.2020 17:14:00 EETPress release

Today the Procter & Gamble Company (NYSE:PG) announced donations totalling $10 million USD in personal health and hygiene, household products, sanitizers and financial support to help people in need, including families, elderly citizens and health professionals, enabling access to everyday essentials. As part of this effort, P&G is donating $1 million to support the International Federation of Red Cross and Red Crescent Societies’ (IFRC) COVID-19 appeal, as well as individual European Red Cross Red Crescent national societies’ efforts, to improve the lives of Europe’s vulnerable people across the continent during these challenging times. Since the onset of the outbreak, P&G has been working with long-standing partner organizations to understand how to best support communities, relief agencies and those impacted by this global emergency. Today, we are taking three immediate actions to support urgent public needs. Supporting vital health care services: We will donate an initial one milli

Diligent Offers Seamless Video Conferencing Access Across All Board Management Platforms to Ensure Secure, Virtual Board Meetings as the Workforce Shifts Remote27.3.2020 17:00:00 EETPress release

Diligent announced today a new, more secure approach to video conferencing across its board management applications – including Diligent Boards for enterprise, BoardEffect for nonprofits, and Community by Diligent for schools and local government – as board meetings and sensitive leadership discussions shift to a remote setting due to the COVID-19 pandemic and in preparation for the future of work. Directors and executives can join confidential virtual meetings with one click from within Diligent’s suite of secure board applications – mitigating the risk associated with sharing meeting invite links to unsecure devices on home networks and personal email accounts that can easily be intercepted. Access to links to virtual meetings within Diligent’s platforms includes leading video applications like Zoom, WebEx, and Go-To-Meeting. This update comes as organizations increase the frequency of confidential board and committee meetings to manage the COVID-19 crisis, in addition to preparing f

Teleroute Opens Its Freight Exchange Platform to Help Transport Companies During Current Crisis27.3.2020 15:05:00 EETPress release

In response to the coronavirus crisis, Teleroute invites transport and logistics companies to join its community free of charge till the end of June. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200327005212/en/ (Photo: Alpega Group) In normal times, more than 200,000 daily freight and vehicle offers are posted on Teleroute. However, the COVID-19 pandemic has led to a drastic increase in the volume of goods required by sectors like retail and pharma. All of this is putting the response capacity of the transport and logistics sector, whose role is key to the management of this crisis, to the test. For this reason, the Teleroute Freight Exchange, part of the Alpega Group, wants to help alleviate the situation by offering free access to all transport and logistics companies that wish to join its platform, till the end of June and without any contractual obligation to prolong. About this initiative, Fabrice Douteaud, Chief Ope

DeltaTrak Announces New Non-Contact Forehead Infrared Thermometer to Aid in Coronavirus Prevention27.3.2020 15:00:00 EETPress release

DeltaTrak®, a leading innovator of cold chain management and temperature monitoring solutions, announces the immediate availability of the new Model 15004 Non-Contact Forehead Infrared Thermometer that serves as a valuable solution in the fight against the Coronavirus. One of the first steps in preventing cross contamination is to measure and screen personnel that may have a fever, which is one of the main symptoms of COVID-19. The need to screen individuals that work together in large workforce environments is imperative to reduce the risk of spreading the infection. The new FDA and CE approved Forehead Infrared Thermometer provides instant readings without necessary contact making it an ideal COVID-19 risk prevention solution. "With so much concern about health and safety at this time, it was important that we provided a solution that can be used to quickly and safely measure body temperature in large group settings," said Frederick Wu, President and CEO of DeltaTrak. "Our focus is p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom